Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral Pharmacology of THC and D-limonene
NCT03609853Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Limonene and dronabinol in cannabis-induced anxiety disorder, sponsored by Johns Hopkins University. Started Apr 2019; status: completed.
02
Drugs
Limonenedronabinol
03
Conditions
cannabis-induced anxiety disorder
Beyond the preview
Go deeper on NCT03609853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609853.